Sreetama Dutt is a news curator and info page creator for the website. She studied biotechnology at SRM Institute of Science and Technology, and did her Masters in medical microbiology at University of Manchester in Manchester, UK.
Zafgen, a biotechnology company developing treatments for obesity and complex metabolic disorders, recently announced the completion of patient recruitment for ZAF-203, a Phase 2b clinical trial for beloranib, a therapy ... Read more
Obesity remains a major public health concern in the United States, where most of the complications due to obesity (including heart attacks, strokes, diabetes, cancer and hypertension) are eventually fatal. ... Read more
Pin It on Pinterest